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Ectosialyltransferase which can add sialic acid to
cell surface acceptor proteins is found in many cells
and its activity is elevated in transplantable and
metastasizing tumour cells (Dobrossy et al., 1981).
Its presence on the surface of L1210 leukaemia cells
has been confirmed ultrastructurally (Porter &
Bernacki, 1975). Recently Maca & Hakes (1978)
have reported high activity of this enzyme in two
human B-cell lines as compared to two human
leukaemic T-cell lines. In order to determine the
value of this enzyme as a marker for certain
haematopoietic cells or their differentiation, we have
examined ectosialyltransferase activity in 23
immunologically characterized human cell lines of
normal and various leukaemia/lymphoma origin
which represent cells at different levels of
maturation (Minowada et al., 1981).
Twenty-three human cell lines, 3 of normal and
20 of various leukaemia/lymphoma origin were
examined. The immunological characteristics of
these cell lines, their origin and their differentiation
stage have been described (Minowada et al., 1981).
All cell lines were grown in RPMI 1640 medium
containing 5% heat inactivated foetal calf serum
and maintained in log phase of growth by
appropriate feeding. At harvest, the cell viability as
determined by trypan blue exclusion test was 90-
95%. Ectosialyltransferase activity was determined
according to the procedure of Maca & Hakes
(1978) with some modifications. Pelleted cells were
washed with 50mm N-2-hydroxy ethyl piperazine-
N', 2-ethanesulfonic acid (HEPES), pH 6.5
containing 0.9% NaCl and 10mm CaCI2. One half
of the cells remained untreated whereas the other
half of cells was treated with 10 units of VIbrio
cholerae neuraminidase (Calbiochem. Behring
Corp.) for 30min at 37°C, pelleted by centrifugation
(800g) and washed with 50mm HEPES, pH 6.5,
containing 0.9% NaCl. Untreated and
neuraminidase treated cells (5 x 106) were suspended
in 0.5ml of 50mM HEPES, pH 6.5-0.9% NaCl
containing 0.1ICi of CMP-sialic acid [sialic-4, 5,
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6, 7, 8, 9-14C, specific activity 213mCimm -, New
England Nuclear] and incubated for 60min at
37°C. The reaction was terminated by addition of
2ml of 1% phosphotungstic acid in 0.5N HCl and
centrifugation. The precipitated material was
washed 3 x with 5% trichloroacetic acid followed
by absolute methanol. The pellets were solubilized
in 0.5ml of NCS solution (Amersham), mixed with
10ml of toluene-based scintillation fluid and
counted using a Packard counter.
All human cell lines examined here (Table)
contained endogenous ectosialyltransferase activity
as measured by incorporation of N-(acetyl-14C)
neuraminic acid from CMP-N-(acetyl-14C)
neuraminic acid to cell ssurface acceptor proteins.
Moreover, as reported for mouse cell line L1210
(Bernacki, 1974) and human cell line Raji (Kilton &
Maca, 1977), neuraminidase treatment of cells prior
to labelling increased assembly of cell surface
sialoproteins several times in most of the cell lines.
Both endogenous ectosialyltransferase activity and
that obtained after neuraminidase treatment were
2-4 times higher in B-cell lines including plasma
cell line RPMI-8226 as compared to T-cell lines
which is in agreement with the finding of Maca &
Hakes (1978) with two T-acute lymphoblastic
leukaemia (T-ALL) and two B-cell lines. No
differences in above enzyme activity were found
between B-cell lines of normal and malignant origin
or between T-ALL cell lines representing T-blasts
and T-chronic lymphocytic leukaemia (T-CLL) line
SKW-3 representing more mature cells. On the
other hand, pre-B cell lines NALM-1 and NALM-6
as well as non-T/non-B cell line NALM-16
expressed lower ectosialyltransferase activity, as
compared to B-cell lines. In addition to B-cell lines
the pre-erythroblast cell line K562 (Lozzio &
Lozzio, 1979) and pre-myeloblast cell line KG-1
(Koeffler et al., 1981) also had higher
ectosialyltransferase activity whereas more mature
myeloid/monocytoid lines ML-2, ML-3, HL-60, and
U-937 had activity comparable to T-cell lines.
These results indicate that ectosialyltransferase
activity is lower in human T-cell lines compared to
© The Macmillan Press Ltd., 1983ECTOSIALYLTRANSFERASE ON HAEMATOPOIETIC CELLS 159
Table Ectosialyltransferase activity of human haematopoietic cell lines
CPM 10-7 Cells
Treated Cells
Neuraminidase Minus
Cell Line Origin Untreated Treated Cells Untreated
T-Cell Lines:
CCRF-CEM ALL 154+40 290+6 136
CEM-A8 ALL 102+17 198 96
RPMI-8402 ALL 122+15 329+30 207
CCRF-HSB2 ALL 174+25 274+ 118 100
MOLT-4 ALL 152 377 + 112 225
SKW-3 CLL 117+33 189+35 72
B-Cell Lines:
RPMI-8057 Normal 202+24 892 + 16 630
RPMI-1788 Normal 309+48 624+93 315
B-89 Normal 144+18 664+75 520
RPMI-8392 ALL 256+18 604+56 348
HRIK BL 258+6 466+46 208
U698M LS 370+33 1284+187 914
JOK-1 HCL 378+6 1140+217 762
RPMI-8226 MM 697+66 1458+213 761
Pre-B-Cell Lines:
NALM-1 CML-BP 134+21 192+38 58
NALM-6 ALL 126+ 16 346+78 220
Non-T-Non B-Cell Line:
NALM-16 ALL 170+14 426+ 18 256
Myeloid Cell Lines:
K-562 CML-BP 204+26 1572+777 1368
KG-1 AML 570 1036+ 180 466
ML-2 AML 148+20 338+ 130 190
ML-3 AML 165+12 253 + 16 88
HL-60 APL 135+24 352+28 217
U-937 HL 177+8 346+ 105 169
(Monoblastoid)
The above values represent mean + standard deviation for 3 separate determinations.
Values without standard deviation are means of 2 determinations. T-cell lines form non-
immune rosettes with sheep red blood cells, B-cell lines have cell surface immunoglobulin,
pre-B-lines have cytoplasmic immunoglobulin M and non-T/non-B line lacks T-, B-, or
myeloid cell markers (Minowada et al., 1981). ALL =acute lymphocytic leukaemia; CLL
=chronic lymophocytic leukaemia; AML =acute myelocytic leukaemia; APL=acute
promyelocytic leukaemia; CML-BP=blastic phase of chronic myelocytic leukaemia; BL
=Burkitt's lymphoma; LS=-lymphosarcoma; HCL=hairy cell leukaemia; MM=multiple
myeloma; HL =histiocytic lymphoma.
B-cell lines and that this activity may increase along
B-cell series and decrease along myeloid series with
maturation. The above results most probably reflect
different patterns of cell surface glyconjugates which
have been proposed to be characteristic for different
hematopoietic cells (Nilsson et al., 1977; Krusius et
al., 1979; Klock et al., 1981).
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